Ingestible event marker data framework

Patent metadata

Field	Value
Publication number	US-11217342-B2
Application number	US-201715498396-A
Country	US
Kind code	B2
Filing date	Apr 26, 2017
Priority date	Jul 8, 2008
Publication date	Jan 4, 2022
Grant date	Jan 4, 2022

Abstract

The ingestible event marker data framework provides a uniform, comprehensive framework to enable various functions and utilities related to ingestible event marker data (IEM data). The functions and utilities include data and/or information having an aspect of data derived from, collected by, aggregated by, or otherwise associated with, an ingestion event.

First claim

What is claimed is:

1. A compliance system, comprising:
an ingestible event marker (IEM) device encoded with a physiologic pattern for a physiologic parameter identifying a patient, the IEM device configured to:
generate a signal comprising the physiologic pattern;
transmit the signal comprising the physiologic pattern through a body of an individual after ingestion by the individual;

a receiver associated with the individual and configured to receive the signal from the IEM device; and
a computer-related device, wherein the computer-related device comprises a processor configured to execute programming logic that causes the computer-related device to:
receive data associated with the signal from the receiver;
measure the physiologic parameter of the individual;
compare the physiologic parameter as measured to the physiologic pattern to confirm that the individual is the patient; and
verify that the individual associated with the physiological pattern has ingested the IEM device.

2. The compliance system of claim 1 , wherein the physiologic parameter comprises at least one of a heart rate variability, a breathing rate, or a heart rate pattern associated with the individual.

3. The compliance system of claim 2 , wherein the heart rate pattern comprises an electrocardiogram (ECG) pattern.

4. The compliance system of claim 1 , wherein the IEM device is integrated with a medication.

5. The compliance system of claim 1 , wherein the receiver comprises a personal signal receiver external to the body of the individual.

6. The compliance system of claim 1 , wherein the computer-related device is further configured to transmit an alert to a mobile device based on the comparison between the measured physiologic parameter and the physiologic pattern.

7. The compliance system of claim 1 , further comprising:
a data source device associated with the body of the individual, wherein the data source device is configured to generate at least one actual data sample of the physiologic parameter from the individual;
wherein the computer-related device is configured to
measure the physiologic parameter of the individual based at least in part on the at least one actual data sample.

8. The compliance system of claim 7 , wherein the data source device comprises an ingestible device, an inhalable device, an injectable device, an implantable device, an insertable device, or an imbibable device.

9. A compliance system, comprising:
an ingestible event marker (IEM) device encoded with a physiologic pattern for a physiologic parameter identifying a patient, the IEM device configured to:
generate a signal comprising the physiologic pattern;
transmit the signal comprising the physiologic pattern through a body of an individual after ingestion by the individual;

a data source device associated with the body of the individual, wherein the data source device is configured to generate at least one actual data sample of the physiologic parameter from the individual; and
a receiver associated with the individual and configured to receive the signal from the IEM device; and
a computer-related device, wherein the computer-related device comprises a processor configured to execute programming logic that causes the computer-related device to:
receive the signal from the receiver;
measure the physiologic parameter of the individual based at least in part on the at least one actual data sample;
compare the physiologic parameter as measured to the physiologic pattern to confirm that the individual is the patient;
and
verify that the individual is the patient and that the IEM device was actually ingested by the patient based, at least in part, on the comparison.

10. The compliance system of claim 9 , wherein the data source device comprises at least one of an inhalable device, an injectable device, an implantable device, an insertable device, and an imbibable device, or combinations thereof.

Assignees

• Otsuka Pharma Co Ltd

Inventors

• O'Reilly David
• Karplus Erika
• Thompson Andrew
• Savage George
• Zdeblick Mark
• Robertson Timothy
• Arne Lawrence
• Behzadi Yashar
• Moon Gregory
• Beaulieu Patrick

Classifications

• G06Q10/40

  Business processes related to social networking or social networking services · CPC title

• G16Y40/10

  Detection; Monitoring · CPC title

• G16Y20/40

  relating to personal data, e.g. biometric data, records or preferences · CPC title

• G16H70/40

  relating to drugs, e.g. their side effects or intended usage · CPC title

• G16H20/00

  ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance · CPC title